TriMas Corp. (TRS)
NASDAQConsumer DiscretionaryPackaging & ContainersSnapshot 2026-09-04
$39.48+1.62%
Close 2026-09-04 · 1-day change
NASDAQConsumer DiscretionaryPackaging & ContainersSnapshot 2026-09-04
QuarterlyIQ Insights · TRS
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Drive year-over-year sales growth of 3% to 6% across Packaging and Specialty Products businesses in 2026.
Stated as a priority in 2 of last 2 quarters. Revenue grew from $168.3 million in 2026-Q1 to $174.6 million in 2026-Q2, a 3.7% increase consistent with the 3% to 6% sales growth target. Management is delivering on this growth priority.
“The Company continues to expect sales growth of 3% to 6% year-over-year across its combined Packaging and Specialty Products businesses.”
“For 2026, the Company continues to expect sales growth of 3% to 6% year-over-year across its combined Packaging and Specialty Products businesses.”
Drive more than 300 basis points of adjusted operating profit margin improvement in 2026 through cost reductions and organizational realignment.
Stated as a priority in 2 of last 2 quarters. Adjusted operating profit increased 29.1% to $14.9 million in 2026-Q2 from $11.5 million in 2025-Q2, reflecting margin improvement driven by cost reduction and realignment initiatives. The trajectory is delivering.
“Adjusted operating profit and margin both improved year-over-year and sequentially from the first quarter of 2026, reflecting the benefits of cost-reduction actions and operational improvement initia…”
“Operating profit margins improved sequentially compared to the fourth quarter of 2025, reflecting cost-reduction and operational improvement initiatives.”
Complete strategic acquisitions to enhance Packaging and Life Sciences platforms and support growth.
Stated as a priority in 2 of last 2 quarters. Management completed the divestiture of TriMas Aerospace in 2026-Q1, generating $1.2 billion net proceeds intended for strategic acquisitions. While no specific acquisitions were announced, the company is positioned to pursue them. Trajectory shows readiness but limited specific delivery so far.
“The Company intends to deploy remaining proceeds for organic growth, strategic acquisitions, and share repurchases.”
“The Company intends to maintain investments until proceeds are deployed for organic growth initiatives, strategic acquisition opportunities or additional share repurchases.”
Return capital to shareholders through disciplined share repurchases following divestiture proceeds.
Stated as a priority in 2 of last 2 quarters. The Company repurchased nearly 2 million shares totaling $73.5 million in first half 2026 and over 5 million shares since November 2025, with $76.5 million still available for repurchases. Management is delivering on this capital return priority.
“Repurchased 509,264 shares for $18.9 million in 2026-Q2; over 5 million shares repurchased since November 2025.”
“Repurchased 1,487,057 shares for $54.5 million in 2026-Q1, contributing to a 3.4% net reduction in shares outstanding.”
Advance realignment and cost-out initiatives to simplify organization and improve operating efficiency, targeting $10.5 million savings in 2026.
Stated as a priority in 2 of last 2 quarters. Management reports being on track to deliver $10.5 million in savings in 2026 from realignment and cost-out initiatives, with facility consolidation completed. The trajectory is delivering as planned.
“TriMas has completed closure and consolidation of Atkins, Arkansas facility and remains on track for $10.5 million savings in 2026.”
“Actions taken in January 2026 expected to generate more than $10 million savings in 2026 and $15 million annualized; additional consolidation planned.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Discretionary names rated neutral grew net income 45% of the time over the next year (vs 59% for the rest of the cohort, n=6943).
Over the trailing year it converted 0.02x of net income into operating cash flow. Historically, Consumer Discretionary names rated fragile grew net income 40% of the time over the next year (vs 53% for the rest of the cohort, n=3652).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to real (inflation-adjusted) rates, long-term interest rates, the US dollar, Fed net liquidity (low R² over the window).
13 material management or governance events in the past 24 months, led by executive changes. Historically, Consumer Discretionary names rated neutral grew net income 48% of the time over the next year (vs 53% for the rest of the cohort, n=2538).
Not investment advice. As of 2026-09-04.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.